Put Options

3 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q3 2023

Nov 07, 2023

SELL
$18.08 - $23.45 $7,231 - $9,380
-400 Reduced 80.0%
100 $0
Q2 2023

Jul 18, 2023

BUY
$20.98 - $31.42 $10,490 - $15,710
500 New
500 $1,000
Q3 2022

Oct 25, 2022

BUY
$17.15 - $30.92 $608,825 - $1.1 Million
35,500 New
35,500 $56,000

Others Institutions Holding AMLX

About Amylyx Pharmaceuticals, Inc.


  • Ticker AMLX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 58,533,200
  • Market Cap $290M
  • Description
  • Amylyx Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, engages in developing various therapeutics for amyotrophic lateral sclerosis (ALS) and other neurodegenerative diseases. The company's product pipeline includes AMX0035, a dual UPR-Bax apoptosis inhibitor composed of sodium phenylbutyrate and taurursodiol for the treatment...
More about AMLX
Track This Portfolio

Track Cutler Group LP Portfolio

Follow Cutler Group LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cutler Group LP, based on Form 13F filings with the SEC.

News

Stay updated on Cutler Group LP with notifications on news.